Arcturus Therapeutics Receives Clearance of an Investigational New Drug Application to U.S. Food and Drug Administration for Arct-032, an Investigational Inhaled Mrna Therapeutic to Treat Cystic Fibrosis
arcturus therapeutics獲得美國食品和藥物管理局針對Arct-032的新藥臨床申請清關,Arct-032是一種用於治療囊性纖維化的新型吸入mRNA治療藥物